Navigation Links
Survival of heart patients on beta-blockers varies greatly with genetic variation

Survival of heart attack and unstable angina patients placed on beta-blocker therapy corresponds to specific variations in their genes, according to a study by researchers at Washington University School of Medicine in St. Louis and the Mid America Heart Institute in Kansas City. The study appears in the September 28, 2005 issue of the Journal of the American Medical Association.

"In our investigation of acute coronary syndrome (ACS) patients discharged on beta-blocker therapy, we were able to associate risk of death with the characteristics of the patients' beta-adrenergic receptor genes," says co-author Howard L. McLeod, Pharm.D., professor of medicine, of genetics and of molecular biology and pharmacology at the School of Medicine. "We identified high-, intermediate- and low-risk groups that had particular variations in these genes, which interact with beta-blocker drugs."

Patients in the high-risk group had a five times higher risk of death than those in the low-risk group according to the hazard ratio, a statistical measure of risk. If further research indicates that beta-blockers are ineffective or create a higher risk in patients with certain variations of beta-adrenergic receptor genes, physicians may modify treatment to improve survival in these patients, according to McLeod.

"These data, while provocative, should not immediately alter current practice," says lead author David E. Lanfear, M.D., formerly of the School of Medicine and now a member of the cardiology staff in the heart failure and cardiac transplant section at Henry Ford Hospital in Detroit. "Further investigation is needed to determine whether the effect seen is due to the lack of efficacy of beta-blockers in higher-risk patients or if genotype alone is responsible for a worse outcome."

Beta-adrenergic receptors in the sympathetic nervous system respond to adrenaline, but beta-blocker drugs block this interaction, slowing the heartbeat and lowering blood pressure
'"/>

Source:Washington University School of Medicine


Page: 1 2 3 4

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis
3. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
4. Survival of the selfless - scientists find cheats dont always prosper
5. Survival of the rarest: Fruit flies shed light on the evolution of behavior
6. UCSD team discovers specialized, rare heart stem cells in newborns
7. Single stem cells from bone heal a broken heart
8. Python a hearty eater
9. Columbia study shows widely used artery clearing device does not help patients during heart attack
10. Researchers reveal secret of key protein in brain and heart function
11. Stem cell therapy successfully treats heart attack in animals
Post Your Comments:
(Date:5/15/2008)...15, 2008) Argonne National Laboratory has signed ...River National Laboratory (SRNL) to collaborate on...rch projects in support of critical U.S. Energy De...priorities. , "The MOU allows Argonne to remain ...ctor Robert Rosner said. "Argonne has the nation,s...
(Date:5/15/2008)...ng a football. Maneuvering through a room full of ... fore. Most would agree these seemingly simple act... a situation. Assistant Professor of Cognitive Sci...gizi argues they require something moreour ability...rly one-tenth of a second to translate the light t...
(Date:5/15/2008)...etected the molecule hydroxyl on another planet fo...an important new tool to unlock the workings of Ve...but difficult-to-detect molecule, is made up of a ...n the upper reaches of the Venusian atmosphere, so...ible and Infrared Thermal Imaging Spectrometer, VI...
(Date:5/15/2008)...actice usually reserved for boosting profits be us...energy use? Writing in the International Journal o...searchers in India provide an answer. , Accordin...ollege of Engineering in Haryana, India, and colle...ont of company efforts. In a global economy with e...
Breaking Biology News(10 mins):Argonne-SRNL agreement supports critical DOE, national priorities 2Crystal (eye) ball: Study says visual system equipped with 'future seeing powers' 2Crystal (eye) ball: Study says visual system equipped with 'future seeing powers' 3Key molecule discovered in Venus's atmosphere 2Adding up business and energy 2NeurogesX to Present at UBS 2007 Global Life Sciences Conference 694 1NeurogesX to Present at UBS 2007 Global Life Sciences Conference 694 2NeurogesX to Present at UBS 2007 Global Life Sciences Conference 694 3Childhood vaccination may protect adult eyes 1609 1Childhood vaccination may protect adult eyes 1609 2Gene chip data improved therapy in some patients with incurable cancer 1607 1Gene chip data improved therapy in some patients with incurable cancer 1607 2Gene chip data improved therapy in some patients with incurable cancer 1607 3Countering Colds With Common Sense 1603 1Countering Colds With Common Sense 1603 2Countering Colds With Common Sense 1603 3
...e a major discovery in basic plant biology that ma...etics or biotechnology. , The scientists have iden... plant cell membranes, where it functions as a tox...s and bacteria can penetrate cell wall barriers an...ein been found that could do this by itself. , Wh...
...er quality by 90 percent in the rivers flowing int...by using two kinds of water-treatment chemicals th.... , The researchers investigated the use of alum,...orus-rich lakes for decades. They also cleaned wat...h polyacrylamide, a new type of polymer used incre...
...ctor" to mean "all-knowing," unfortunately, this w...rt of medical professionals sometimes leads to dev...l suffering, or even death, for their patients. , ...l diagnoses through the development of new technol... is putting her engineering knowledge to work to d...
...n Australia and people can still safely eat chicke...pecialist Dr Bob Doneley. , "The chances of getti...s are so infinitesimally small," UQ School of Vete... , "You,re more likely to have a light plane hit ...tting bird flu off their cockatiel." , Dr Donele...
Other Biology News:Biologists discover new pathway into plant cells 2Biologists discover new pathway into plant cells 3UCR environmental scientists propose chemical solution to cleaning California's Salton Sea 2UCR environmental scientists propose chemical solution to cleaning California's Salton Sea 3Making medicine 'smarter' 2Expert dispels bird flu paranoia 2
(Date:5/15/2008)...Calif., May 15 /- NeurogesX...ny focused on developing novel,pain management the...esent,on Monday, May 19, 2008 at the Rodman & Rens...ny DiTonno, President and Chief Executive,Officer,...inancial Officer,will be available to respond to ...
(Date:5/15/2008)... May 15 /- Escalon Medical ... its fiscal third quarter and,nine months ended Ma...08, product revenue increased 18% to,$8,139,000 co... last fiscal,year. Product revenues were driven by... units., Net revenue for the third quarter of fis...
(Date:5/15/2008)...d BARCELONA, Spain, May 15 /PRNewswire-FirstCall/ ...boratorios Almirall, S.A. (ALM.MC),will host a web...e-clinical,data findings presented at the American...ich will include a slide presentation and a Q&A se...30am New York time, 3:30pm CET,2:30pm UKT., (Log...
(Date:5/15/2008)...ncides with the ,60s cleanup of toxic pollution in...ton, SEATTLE, May 15 /- Evolution is..., at least in the case of a little fish called the...ative warp-speed reverse,according to a study led...,Center and published online today ahead of print ...
Breaking Biology Technology:NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 2NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference 3Escalon(R) Reports Third Quarter Fiscal 2008 Results 2Escalon(R) Reports Third Quarter Fiscal 2008 Results 3Escalon(R) Reports Third Quarter Fiscal 2008 Results 4Escalon(R) Reports Third Quarter Fiscal 2008 Results 5Escalon(R) Reports Third Quarter Fiscal 2008 Results 6Escalon(R) Reports Third Quarter Fiscal 2008 Results 7Escalon(R) Reports Third Quarter Fiscal 2008 Results 8Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress 2Researchers Document Rapid, Dramatic 'Reverse Evolution' in the Threespine Stickleback Fish 2Researchers Document Rapid, Dramatic 'Reverse Evolution' in the Threespine Stickleback Fish 3Researchers Document Rapid, Dramatic 'Reverse Evolution' in the Threespine Stickleback Fish 4
... Inc. has received a $500,000 federal research gr...s awarded a phase II small-business innovation res... to continue work on an antibacterial treatment. T...the company received last year for the same techno...operating officer, the grant will help fund the fi...
...st Wisconsin Manufacturing Outreach Center MENOMO...Outreach Center at the University of Wisconsin-S...epartment of Commerce and the National Institute...review-panel presentation for several distinctions...50 centers and branches of Manufacturing Extension...
...w a truthful employment ad for the job of Universi...P WANTED Major Midwest university system seeks a ...p the following groups happy: Board of Regents, pr...cellors, most of whom can overrule or ignore you. ...are prone to micromanage. Academic responsibilitie...
...pact Seven use Wisconsin Impact Fund to distribute...s. Source: Novation Technology Campus Web site . ...ned $3.5 million to The Alexander Company , the d... side, as part of a federal program designed to bo...kets Tax Credit Program offers private investors ...
Other Biology Technology:ConjuGon receives $500,000 to battle bacteria 2Choice of next UW president comes down to matching skills with the challenge 2Choice of next UW president comes down to matching skills with the challenge 3Novation Technology Campus gets $3.5 million boost 2
DETACHaBEAD Mouse CD4 from Dynal Biotech
Antibodies were affinity purified using epitopes specific to USP33 immobilized on solid support.
10% Normal Goat Serum from Invitrogen
This monoclonal antibody recognizes 30% of IgM-rheumatoid factor paraproteins from unrelated individuals. It does not cross-react with IgM, IgA, or IgG proteins lacking rheumatoid factor nor with p
Biology Products: